National Vision Holdings, Inc. Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities
National Vision Holdings, Inc. (EYE) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities of 0 shares for the 3-month period ending 2024-03-30, per its 10-Q filed 2024-05-08.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities · last filed 2024-05-08
- National Vision Holdings, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2024-03-30 was 0.00 shares, a 100.00% decline year-over-year.
- National Vision Holdings, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2023-09-30 was 0.00 shares.
- National Vision Holdings, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2023-07-01 was 0.00 shares.
- National Vision Holdings, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2023-04-01 was 12.91M shares, a 0.00% change year-over-year.
- National Vision Holdings, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2023 was 0.00 shares.
- National Vision Holdings, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2022 was 0.00 shares, a 100.00% decline from fiscal 2022.
- National Vision Holdings, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2022 was 12.91M shares, a 4092.21% increase from fiscal 2021.
- National Vision Holdings, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2021 was 308.00K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 3 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 6 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 9 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 12 month |
|---|---|---|---|---|
| 2024-03-30 | 0.00 shares 10-Q · filed 2024-05-08 | |||
| 2023-12-30 | 0.00 shares 10-K · filed 2024-02-27 | |||
| 2023-09-30 | 0.00 shares 10-Q · filed 2023-11-09 | 0.00 shares 10-Q · filed 2023-11-09 | ||
| 2023-07-01 | 0.00 shares 10-Q · filed 2023-08-10 | 0.00 shares 10-Q · filed 2023-08-10 | ||
| 2023-04-01 | 12.91M shares 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | 0.00 shares 10-K · filed 2024-02-27 | |||
| 2022-10-01 | 0.00 shares 10-Q · filed 2023-11-09 | 12.91M shares 10-Q · filed 2023-11-09 | ||
| 2022-07-02 | 0.00 shares 10-Q · filed 2023-08-10 | 12.91M shares 10-Q · filed 2023-08-10 | ||
| 2022-04-02 | 12.91M shares 10-Q · filed 2023-05-11 | |||
| 2022-01-01 | 12.91M shares 10-K · filed 2024-02-27 | |||
| 2021-10-02 | 12.91M shares 10-Q · filed 2022-11-10 | 12.91M shares 10-Q · filed 2022-11-10 | ||
| 2021-07-03 | 12.91M shares 10-Q · filed 2022-08-11 | 12.91M shares 10-Q · filed 2022-08-11 | ||
| 2021-04-03 | 12.91M shares 10-Q · filed 2022-05-10 | |||
| 2021-01-02 | 308.00K shares 10-K · filed 2023-03-01 | |||
| 2020-09-26 | 1.23M shares 10-Q · filed 2021-11-10 | 410.00K shares 10-Q · filed 2021-11-10 | ||
| 2020-06-27 | 0.00 shares 10-Q · filed 2021-08-12 | 0.00 shares 10-Q · filed 2021-08-12 | ||
| 2020-03-28 | 0.00 shares 10-Q · filed 2021-05-13 | |||
| 2019-12-28 | 0.00 shares 10-K · filed 2022-02-28 | |||
| 2019-09-28 | 0.00 shares 10-Q · filed 2020-11-05 | 0.00 shares 10-Q · filed 2020-11-05 | ||
| 2018-12-29 | 0.00 shares 10-K · filed 2021-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |